FIELD: pharmaceutics.
SUBSTANCE: invention relates to a method of producing 4-(benzylcarbamoyl)-3-hydroxy-1-methylpyridine-1-iodide, wherein the starting material used is ethyl ester of 3-hydroxyizonicotinic acid, with its subsequent heating to 120 °C, characterized by that the ethyl ether is heated for 6 hours.
EFFECT: method of producing 4-(benzylcarbamoyl)-3-hydroxy-1-methylpyridine-1-iodide, which can be used for treating neuroinfections.
1 cl, 6 ex, 12 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF STUDYING THE PHARMACOKINETIC PROPERTIES OF A MEDICINAL PRODUCT WITH ENISAMIA IODIDE ACTIVE SUBSTANCE | 2022 |
|
RU2802260C1 |
| USE OF ENISAMIUM IODIDE FOR THE PREVENTION AND/OR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) | 2022 |
|
RU2799328C1 |
| AGENT REPRESENTING 5-AMINO-6-METHYLURACIL AND EXHIBITING ANTIOXIDANT ACTIVITY AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2398767C2 |
| METHOD FOR THE CORRECTION OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 3-HYDROXY-2-ETHYL-6-METHYLPYRIDINIUM NICOTINATE IN EXPERIMENT | 2021 |
|
RU2763011C1 |
| 2-(1'-HYDROXY-4'-ISOPROPYLENE-1'-METHYLCYCLOHEXYL-2'-THIO)-METHYL ETHANOATE EXHIBITING FUNGICIDAL AND ANTI-INFLAMMATORY ACTION | 2010 |
|
RU2431479C2 |
| COMBINED DRUG PREPARATION IN FORM OF SOLUTION FOR PREPARING SPRAY FOR TREATING DISEASES OF ORAL CAVITY | 2018 |
|
RU2687745C1 |
| FLUOROQUINOLONES BASED ON 4-DEOXYPYRIDOXINE | 2016 |
|
RU2634122C1 |
| NON-STEROID ANTI-INFLAMMATORY AGENTS BASED ON PYRIDOXINE DERIVATIVES | 2012 |
|
RU2513089C1 |
| COMPLEX OF BIOLOGICALLY ACTIVE SUBSTANCES FOR TREATING AND PREVENTING CARDIOVASCULAR DISEASES | 2013 |
|
RU2520695C1 |
| METHOD FOR CORRECTION OF PLACENTAL MICROCIRCULATION DISORDER WITH SUBSTANCE OF 3-HYDROXY-2-ETHYL-6-METHYLPYRIDINIUM NICOTINATE IN ADMA-LIKE MODEL OF PREECLAMPSIA | 2020 |
|
RU2735766C1 |
